Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marcelo F. Di Carli, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Marcelo Di Carli and Ron Blankstein.
Marcelo Di Carli
Connection Strength
21.473
Ron Blankstein
  1. Coronary Plaque Volume and Stenosis: Important Determinants of Myocardial Ischemia. J Am Coll Cardiol. 2018 02 06; 71(5):510-512.
    View in: PubMed
    Score: 0.795
  2. Quantifying Plaque Burden and Morphology Using Coronary Computed Tomography Angiography to Predict Coronary Physiology: Helpful…But Is It Sufficient? Circ Cardiovasc Imaging. 2015 Oct; 8(10):e004058.
    View in: PubMed
    Score: 0.675
  3. Reply: (18)F-FDG imaging in patients with "suspected," but not "proven," sarcoidosis. J Am Coll Cardiol. 2014 Aug 12; 64(6):631.
    View in: PubMed
    Score: 0.624
  4. Low yield of routine preoperative coronary computed tomography angiography in patients evaluated for liver transplantation. Circulation. 2014 Oct 14; 130(16):1337-9.
    View in: PubMed
    Score: 0.623
  5. Reply: Cardiac positron emission tomography as a prognostic indicator of cardiac sarcoidosis. J Am Coll Cardiol. 2014 Jun 17; 63(23):2590.
    View in: PubMed
    Score: 0.609
  6. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014 Feb 04; 63(4):329-36.
    View in: PubMed
    Score: 0.590
  7. Integration of coronary anatomy and myocardial perfusion imaging. Nat Rev Cardiol. 2010 Apr; 7(4):226-36.
    View in: PubMed
    Score: 0.459
  8. Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction: The Mass General Brigham YOUNG-MI Registry. JAMA Cardiol. 2021 May 19.
    View in: PubMed
    Score: 0.249
  9. Role of Cardiac CT in Pre-Procedure Planning for Transcatheter Mitral Valve Replacement. JACC Cardiovasc Imaging. 2021 Apr 07.
    View in: PubMed
    Score: 0.247
  10. Association of inflammatory disease and long-term outcomes among young adults with myocardial infarction: the Mass General Brigham YOUNG-MI Registry. Eur J Prev Cardiol. 2021 Mar 30.
    View in: PubMed
    Score: 0.247
  11. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021 Mar 10.
    View in: PubMed
    Score: 0.246
  12. Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients. J Nucl Cardiol. 2021 Jan 04.
    View in: PubMed
    Score: 0.243
  13. Use of cardiac CT amidst the COVID-19 pandemic and beyond: North American perspective. J Cardiovasc Comput Tomogr. 2021 Jan-Feb; 15(1):16-26.
    View in: PubMed
    Score: 0.241
  14. Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry. Eur Heart J. 2020 11 07; 41(42):4127-4137.
    View in: PubMed
    Score: 0.240
  15. What is Multimodality Cardiovascular Imaging and How Can It Be Delivered? Heart. 2020 Oct 27.
    View in: PubMed
    Score: 0.240
  16. Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry. Clin Cardiol. 2020 Nov; 43(11):1209-1215.
    View in: PubMed
    Score: 0.238
  17. Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med. 2021 May 10; 62(5):716-722.
    View in: PubMed
    Score: 0.238
  18. Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation. J Nucl Cardiol. 2020 Jul 20.
    View in: PubMed
    Score: 0.235
  19. Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI Registry. JAMA Netw Open. 2020 07 01; 3(7):e209649.
    View in: PubMed
    Score: 0.235
  20. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2020 07 01; 41(25):2366-2375.
    View in: PubMed
    Score: 0.235
  21. Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry. Eur J Prev Cardiol. 2020 Jun 23.
    View in: PubMed
    Score: 0.234
  22. Atherosclerotic cardiovascular disease risk and elevated lipoprotein(a) among young adults with myocardial infarction: The Partners YOUNG-MI Registry. Eur J Prev Cardiol. 2020 Jun 15; 2047487320931296.
    View in: PubMed
    Score: 0.234
  23. Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2020 06 09; 75(22):2804-2815.
    View in: PubMed
    Score: 0.234
  24. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2020 May 17.
    View in: PubMed
    Score: 0.233
  25. Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults. J Am Coll Cardiol. 2020 03 10; 75(9):1003-1013.
    View in: PubMed
    Score: 0.230
  26. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33.
    View in: PubMed
    Score: 0.225
  27. Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry. Am J Med. 2020 05; 133(5):605-612.e1.
    View in: PubMed
    Score: 0.224
  28. Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry. Diabetes Care. 2020 08; 43(8):1843-1850.
    View in: PubMed
    Score: 0.222
  29. Stress Myocardial Blood Flow Ratio by Dynamic CT Perfusion Identifies Hemodynamically Significant CAD. JACC Cardiovasc Imaging. 2020 04; 13(4):966-976.
    View in: PubMed
    Score: 0.222
  30. Response by Divakaran et al to Letter Regarding Article, "Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis: An Imaging-Histologic Correlation Study in Patients Undergoing Cardiac Transplantation". Circ Cardiovasc Imaging. 2019 08; 12(8):e009622.
    View in: PubMed
    Score: 0.221
  31. Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study. J Nucl Cardiol. 2019 Jun 13.
    View in: PubMed
    Score: 0.218
  32. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
    View in: PubMed
    Score: 0.218
  33. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2019 05 21; 73(19):2439-2450.
    View in: PubMed
    Score: 0.217
  34. Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis. J Nucl Cardiol. 2021 Apr; 28(2):579-588.
    View in: PubMed
    Score: 0.216
  35. Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes. J Am Heart Assoc. 2019 01 08; 8(1):e007829.
    View in: PubMed
    Score: 0.212
  36. Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction. Circulation. 2018 12 11; 138(24):2855-2857.
    View in: PubMed
    Score: 0.211
  37. Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2019 02; 26(1):188-199.
    View in: PubMed
    Score: 0.209
  38. Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 Aug; 25(4):1147.
    View in: PubMed
    Score: 0.205
  39. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. JACC Clin Electrophysiol. 2018 09; 4(9):1200-1210.
    View in: PubMed
    Score: 0.205
  40. Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction. J Am Coll Cardiol. 2018 06 05; 71(22):2540-2551.
    View in: PubMed
    Score: 0.200
  41. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018 03 07; 39(10):840-849.
    View in: PubMed
    Score: 0.200
  42. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 01 21; 39(4):316-323.
    View in: PubMed
    Score: 0.198
  43. Causes of Troponin Elevation and Associated Mortality in Young Patients. Am J Med. 2018 03; 131(3):284-292.e1.
    View in: PubMed
    Score: 0.198
  44. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2018 01; 11(1):e007030.
    View in: PubMed
    Score: 0.197
  45. Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. J Am Coll Cardiol. 2017 12 05; 70(22):2835-2837.
    View in: PubMed
    Score: 0.196
  46. Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. J Am Coll Cardiol. 2018 01 23; 71(3):292-302.
    View in: PubMed
    Score: 0.195
  47. Use of Cardiac Computerized Tomography to Predict Neo-Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve Replacement. J Am Heart Assoc. 2017 11 04; 6(11).
    View in: PubMed
    Score: 0.195
  48. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018 02; 93(2):501-509.
    View in: PubMed
    Score: 0.194
  49. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017 10; 24(5):1741-1758.
    View in: PubMed
    Score: 0.194
  50. Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease. Circulation. 2017 Dec 12; 136(24):2325-2336.
    View in: PubMed
    Score: 0.193
  51. Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry. Clin Cardiol. 2017 Nov; 40(11):955-961.
    View in: PubMed
    Score: 0.192
  52. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function. J Am Heart Assoc. 2017 May 04; 6(5).
    View in: PubMed
    Score: 0.188
  53. Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry. Cardiovasc Diabetol. 2017 01 25; 16(1):14.
    View in: PubMed
    Score: 0.185
  54. Role of Imaging in Evaluating Infiltrative Heart Disease. Curr Treat Options Cardiovasc Med. 2017 Jan; 19(1):3.
    View in: PubMed
    Score: 0.184
  55. Transthoracic Echocardiography to Assess Aortic Regurgitation after TAVR: A Comparison with Periprocedural Transesophageal Echocardiography. Cardiology. 2017; 137(1):1-8.
    View in: PubMed
    Score: 0.183
  56. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2017 02 07; 135(6):566-577.
    View in: PubMed
    Score: 0.182
  57. The value of noninvasive computed tomography derived fractional flow reserve in our current approach to the evaluation of coronary artery stenosis. Curr Opin Cardiol. 2016 11; 31(6):970-976.
    View in: PubMed
    Score: 0.182
  58. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 08; 25(4):1136-1146.
    View in: PubMed
    Score: 0.180
  59. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis. Circ Cardiovasc Imaging. 2016 Sep; 9(9):e005001.
    View in: PubMed
    Score: 0.180
  60. European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners Registry. Circulation. 2016 Jul 19; 134(3):201-11.
    View in: PubMed
    Score: 0.178
  61. Clinical Outcomes After Evaluation of Stable Chest Pain by Coronary Computed Tomographic Angiography Versus Usual Care: A Meta-Analysis. Circ Cardiovasc Imaging. 2016 Apr; 9(4):e004419.
    View in: PubMed
    Score: 0.175
  62. Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA. Eur Heart J Cardiovasc Imaging. 2017 Feb; 18(2):224-235.
    View in: PubMed
    Score: 0.173
  63. 3D printing based on cardiac CT assists anatomic visualization prior to transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2016 Jan-Feb; 10(1):28-36.
    View in: PubMed
    Score: 0.171
  64. Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol. 2016 06; 27(6):1823-9.
    View in: PubMed
    Score: 0.169
  65. Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. Eur Heart J Cardiovasc Imaging. 2015 Dec; 16(12):1338-46.
    View in: PubMed
    Score: 0.164
  66. Response to letter regarding article, "effects of sex on coronary microvascular dysfunction and cardiac outcomes". Circulation. 2015 Mar 17; 131(11):e376.
    View in: PubMed
    Score: 0.163
  67. Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging. J Nucl Med. 2015 Apr; 56(4):592-9.
    View in: PubMed
    Score: 0.162
  68. Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015 Aug; 16(8):900-9.
    View in: PubMed
    Score: 0.162
  69. Incremental prognostic value of kidney function decline over coronary artery disease for cardiovascular event prediction after coronary computed tomography. Kidney Int. 2015 Jul; 88(1):152-9.
    View in: PubMed
    Score: 0.161
  70. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015 Feb 10; 131(6):528-35.
    View in: PubMed
    Score: 0.159
  71. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015 Jan 06; 131(1):19-27.
    View in: PubMed
    Score: 0.159
  72. Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol. Circ Cardiovasc Imaging. 2014 Jul; 7(4):629-38.
    View in: PubMed
    Score: 0.154
  73. Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11.
    View in: PubMed
    Score: 0.153
  74. Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography. Curr Cardiol Rep. 2014 May; 16(5):483.
    View in: PubMed
    Score: 0.153
  75. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014 Jun 17; 129(24):2518-27.
    View in: PubMed
    Score: 0.153
  76. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging. 2014 Mar; 7(2):282-91.
    View in: PubMed
    Score: 0.151
  77. Yield of downstream tests after exercise treadmill testing: a prospective cohort study. J Am Coll Cardiol. 2014 Apr 08; 63(13):1264-1274.
    View in: PubMed
    Score: 0.151
  78. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014 Feb; 55(2):248-55.
    View in: PubMed
    Score: 0.150
  79. Incremental prognostic value of coronary artery calcium score versus CT angiography among symptomatic patients without known coronary artery disease. Atherosclerosis. 2014 Mar; 233(1):190-5.
    View in: PubMed
    Score: 0.150
  80. Reduction in ¹8F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014 Feb; 21(1):166-74.
    View in: PubMed
    Score: 0.149
  81. Cardiometabolic risk is associated with atherosclerotic burden and prognosis: results from the partners coronary computed tomography angiography registry. Diabetes Care. 2014 Feb; 37(2):555-64.
    View in: PubMed
    Score: 0.147
  82. Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. J Nucl Cardiol. 2013 Apr; 20(2):310-2.
    View in: PubMed
    Score: 0.142
  83. Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease. J Am Coll Cardiol. 2013 May 21; 61(20):2098-106.
    View in: PubMed
    Score: 0.142
  84. Meta-analysis of coronary CT angiography in the emergency department. Eur Heart J Cardiovasc Imaging. 2013 Jun; 14(6):607.
    View in: PubMed
    Score: 0.141
  85. Outcomes after coronary computed tomography angiography in the emergency department: a systematic review and meta-analysis of randomized, controlled trials. J Am Coll Cardiol. 2013 Feb 26; 61(8):880-92.
    View in: PubMed
    Score: 0.141
  86. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012 Oct; 5(10):1025-34.
    View in: PubMed
    Score: 0.137
  87. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012 Oct 09; 126(15):1858-68.
    View in: PubMed
    Score: 0.136
  88. Use of high-risk features from exercise treadmill testing to identify obstructive left main disease with normal myocardial perfusion imaging. J Nucl Cardiol. 2012 Aug; 19(4):814-7.
    View in: PubMed
    Score: 0.136
  89. Correlative imaging of spontaneous coronary artery dissection. J Nucl Cardiol. 2012 Jun; 19(3):625-9.
    View in: PubMed
    Score: 0.134
  90. Comparison of cardiac computed tomography examination appropriateness under the 2010 revised versus the 2006 original Appropriate Use Criteria. J Cardiovasc Comput Tomogr. 2012 Mar-Apr; 6(2):99-107.
    View in: PubMed
    Score: 0.131
  91. Comparison of the Diamond-Forrester method and Duke Clinical Score to predict obstructive coronary artery disease by computed tomographic angiography. Am J Cardiol. 2012 Apr 01; 109(7):998-1004.
    View in: PubMed
    Score: 0.130
  92. Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. J Am Coll Cardiol. 2011 Oct 18; 58(17):1807-16.
    View in: PubMed
    Score: 0.128
  93. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011 Nov 15; 124(20):2215-24.
    View in: PubMed
    Score: 0.128
  94. Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET. J Nucl Cardiol. 2010 Apr; 17(2):328-32.
    View in: PubMed
    Score: 0.115
  95. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2020 Sep 11.
    View in: PubMed
    Score: 0.059
  96. Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 09 15; 76(11):1345-1357.
    View in: PubMed
    Score: 0.059
  97. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. J Nucl Cardiol. 2019 Nov 18.
    View in: PubMed
    Score: 0.056
  98. Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes. Radiol Cardiothorac Imaging. 2019 Jun; 1(2):e180018.
    View in: PubMed
    Score: 0.055
  99. Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019 05; 291(2):330-337.
    View in: PubMed
    Score: 0.054
  100. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. J Am Coll Cardiol. 2018 08 14; 72(7):707-717.
    View in: PubMed
    Score: 0.051
  101. Evolving, innovating, and revolutionary changes in cardiovascular imaging: We've only just begun! J Nucl Cardiol. 2018 06; 25(3):758-768.
    View in: PubMed
    Score: 0.050
  102. Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association. Circ Cardiovasc Imaging. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.049
  103. Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med. 2017 08; 58(8):1341-1353.
    View in: PubMed
    Score: 0.048
  104. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer? J Nucl Cardiol. 2017 10; 24(5):1610-1618.
    View in: PubMed
    Score: 0.048
  105. Feasibility study of electrocardiographic and respiratory gated, gadolinium enhanced magnetic resonance angiography of pulmonary veins and the impact of heart rate and rhythm on study quality. J Cardiovasc Magn Reson. 2014 Jun 19; 16:43.
    View in: PubMed
    Score: 0.039
  106. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013 Oct; 54(10):1748-54.
    View in: PubMed
    Score: 0.036
  107. Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation. 2013 Aug 06; 128(6):605-14.
    View in: PubMed
    Score: 0.036
  108. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Cardiol. 2012 Oct; 19(5):970-8.
    View in: PubMed
    Score: 0.033
  109. Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. JACC Cardiovasc Imaging. 2011 Aug; 4(8):850-61.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.